Sphera Funds Management Ltd. Alx Oncology Holdings Inc Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$21.49 - $74.4 $2.77 Million - $9.58 Million	-128,706 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$52.51 - $80.91 $3.36 Million - $5.18 Million	-64,022 Reduced 33.22%	128,706 $9.51 Million
Q2 2021 Aug 17, 2021	BUY	$52.2 - $75.23 $3.26 Million - $4.69 Million	62,377 Added 47.85%	192,728 $10.5 Million
Q1 2021 May 17, 2021	SELL	$62.84 - $87.68 $194,615 - $271,544	-3,097 Reduced 2.32%	130,351 $9.61 Million
Q4 2020 Feb 16, 2021	SELL	$34.11 - $112.26 $1.66 Million - $5.46 Million	-48,622 Reduced 26.71%	133,448 $11.5 Million
Q3 2020 Nov 12, 2020	BUY	$29.36 - $47.1 $5.35 Million - $8.58 Million	182,070 New	182,070 $6.87 Million

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $66M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.